GO
Loading...

Government Agencies

More

  • TOKYO, April 1- Asian shares were down slightly in early trade on Tuesday, as investors chose discretion over valour ahead of a key manufacturing survey from China even as Federal Reserve Chair Janet Yellen's dovish comments eased concerns of an early start to rate hikes.

  • CHICAGO, March 31- Federal Reserve Chair Janet Yellen on Monday took a page from a politician's playbook to defend the U.S. central bank's easy-money policies, citing the struggles of three Americans in a speech and touring a college workshop to shake hands with students and teachers.

  • NEW YORK, March 31- Longer-dated U.S. Treasuries yields edged higher on Monday on expectations for an upbeat U.S. jobs report on Friday, while intermediate-dated notes stabilized after dovish remarks from Federal Reserve Chair Janet Yellen.

  • *S&P 500 rises in Q1 for its fifth straight quarterly gain. NEW YORK, March 31- U.S. stocks rose on Monday, with the S&P 500 ending both March and the first quarter of 2014 with moderate gains, after Federal Reserve Chair Janet Yellen relieved concerns about a rate hike coming earlier than expected.

  • March 31- Durata Therapeutics Inc's drug to treat acute bacterial skin infections shows substantial evidence of safety and efficacy, a panel of advisers to the U.S. Food and Drug Administration concluded on Monday. The FDA is not obliged to follow the advice of its expert panels but typically does so.

  • March 31- Durata Therapeutics Inc's drug to treat acute bacterial skin infections shows substantial evidence of safety and efficacy, a panel of advisers to the U.S. Food and Drug Administration concluded on Monday. The panel voted unanimously in favor of the drug, dalbavancin, paving the way for its approval.

  • The U.S. dollar index of major currencies, coming off three days of gains, was down 0.11 percent to 80.089 in late afternoon New York trade after dipping below 80 in the wake of a speech in Chicago by Federal Reserve Chair Janet Yellen.

  • *S&P on track for fifth straight quarterly advance. NEW YORK, March 31- U.S. stocks rose on Monday, with the S&P 500 on track to end the first quarter of 2014 with slight gains, after Federal Reserve Chair Janet Yellen calmed concerns about a rate hike coming earlier than expected. Micron Tech climbed 7.2 percent to $23.48 while Oracle Corp added 3.6 percent to $40.98.

  • *USDA sees U.S. corn acres down sharply from 2013. CHICAGO, March 31- U.S. corn futures on Monday climbed above $5 per bushel for the first time since September after a highly anticipated U.S. crop report revealed that inventories were smaller than expected on March 1.

  • *Russia says battalion withdrawing from near Ukraine border. NEW YORK, March 31- Crude futures dipped in volatile end-of-quarter trading on Monday, pressured by news Russia was withdrawing some troops on the Ukrainian border and concerns about the struggling U.S. labor market voiced by Federal Reserve Chair Janet Yellen.

  • NEW YORK, March 31- Crude futures were mixed in volatile end-of-quarter trading on Monday, after turning lower on news Russia was withdrawing some troops on the Ukrainian border and concerns about the struggling U.S. labor market voiced by Federal Reserve Chair Janet Yellen.

  • *Asia stocks outside Japan hit highest level in 2014. NEW YORK, March 31- Stocks in major markets rose for a fifth straight session on Monday while gold, the yen and other safety assets fell after Federal Reserve Chair Janet Yellen reinforced the need for "extraordinary" commitment to support the U.S. economy.

  • March 31- Curis Inc said the U.S. Food and Drug Administration allowed it to resume testing of its experimental cancer drug, lifting a November order halting enrolment in an early-stage trial. Curis acquired the license to develop and market the treatment from Genentech, a unit of the Roche Holding AG, for an upfront payment of $9.5 million in November 2012.

  • NEW YORK, March 31- U.S. stocks were poised to open higher on Monday, putting the S&P 500 on track for a second straight advance, ahead of a speech by Federal Reserve Chair Janet Yellen. *Investors will peruse comments by Yellen, who is scheduled to speak in Chicago at 9:55 a.m. EST, for clues on her stance on interest rates.

  • FDA allows Curis to resume testing cancer drug Monday, 31 Mar 2014 | 7:44 AM ET

    March 31- Curis Inc said the U.S. Food and Drug Administration allowed it to resume testing its experimental cancer drug, lifting a November order halting enrolment in an early-stage trial. The company's shares jumped about 22 percent to $3.35 in trading before the bell. The Lexington, Massachusetts- based company's shares closed at $2.75 on the Nasdaq on Friday.

  • US STOCKS-Futures climb with Yellen on tap Monday, 31 Mar 2014 | 7:41 AM ET

    NEW YORK, March 31- U.S. stock index futures rose on Monday, indicating the S&P 500 will climb for a second straight session, ahead of a speech by Federal Reserve Chair Janet Yellen. *Yellen is scheduled to speak in Chicago at 9:55 a.m. EST and investors will monitor her comments for her stance on interest rates.

  • DIARY - Top economic Events to April 9 Friday, 28 Mar 2014 | 8:01 PM ET

    BERLIN- Bundesbank President Jens Weidmann speaks at the 53rd ACI Financial Markets World Congress "Financial Integration in Europe"- 0930 GMT. Speakers:- Federal Reserve Chair Janet Yellen, FDIC Chairman Martin Gruenberg and Comptroller of the Currency Thomas Curry. BRUSSELS- 5th EU-Africa Business Forum.

  • March 28- Biogen Idec Inc has won U.S. approval for its long-acting hemophilia B treatment Alprolix, the U.S. Food and Drug Administration said on Friday. It affects about 4,000 people in the United States and 25,000 worldwide.

  • KANSAS CITY, Mo., March 28- A top Federal Reserve official who has often warned of the risks of keeping U.S. interest rates too low for too long said on Friday she wants to see how winding down the Fed's massive bond-buying stimulus goes before setting out any path for rate hikes.

  • Teen's experiment can save US millions Friday, 28 Mar 2014 | 2:07 PM ET

    He's only 14, but Suvir Mirchandani figured out how to save the government millions, according to a report.